Humacyte, Inc.Humacyte, Inc.Humacyte, Inc.

Humacyte, Inc.

No trades
See on Supercharts

HUMA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
HUMA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company